[go: up one dir, main page]

AU2001288961A1 - Lipoteichoic acid immunogenic compositions and methods of making and using thereof - Google Patents

Lipoteichoic acid immunogenic compositions and methods of making and using thereof

Info

Publication number
AU2001288961A1
AU2001288961A1 AU2001288961A AU8896101A AU2001288961A1 AU 2001288961 A1 AU2001288961 A1 AU 2001288961A1 AU 2001288961 A AU2001288961 A AU 2001288961A AU 8896101 A AU8896101 A AU 8896101A AU 2001288961 A1 AU2001288961 A1 AU 2001288961A1
Authority
AU
Australia
Prior art keywords
making
methods
immunogenic compositions
lipoteichoic acid
acid immunogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001288961A
Other languages
English (en)
Inventor
Joseph J. Drabick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Army Medical Research and Development Command
Original Assignee
US Army Medical Research Institute of Infectious Diseases
US Army Medical Research and Development Command
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Army Medical Research Institute of Infectious Diseases, US Army Medical Research and Development Command filed Critical US Army Medical Research Institute of Infectious Diseases
Publication of AU2001288961A1 publication Critical patent/AU2001288961A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/07—Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/622—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier non-covalent binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001288961A 2000-09-12 2001-09-10 Lipoteichoic acid immunogenic compositions and methods of making and using thereof Abandoned AU2001288961A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23195900P 2000-09-12 2000-09-12
US60/231,959 2000-12-09
PCT/US2001/028217 WO2002045742A2 (fr) 2000-09-12 2001-09-10 Compositions immunogeniques d'acide lipoteichoique et procedes de preparation et d'utilisation associes

Publications (1)

Publication Number Publication Date
AU2001288961A1 true AU2001288961A1 (en) 2002-06-18

Family

ID=22871328

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001288961A Abandoned AU2001288961A1 (en) 2000-09-12 2001-09-10 Lipoteichoic acid immunogenic compositions and methods of making and using thereof

Country Status (3)

Country Link
US (2) US20020051793A1 (fr)
AU (1) AU2001288961A1 (fr)
WO (1) WO2002045742A2 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060121058A1 (en) * 2002-08-08 2006-06-08 Children's Medical Center Corporation Anti-pneumococcal preparations
JP2006514636A (ja) * 2002-12-02 2006-05-11 バイオシネクサス インコーポレーテッド 抗ブドウ球菌療法およびワクチンの標的としての壁テイコイン酸
CA2518960C (fr) * 2003-03-14 2013-08-27 Sinexus, Inc. Administration dans un sinus d'agents therapeutiques a liberation prolongee
GB2408573A (en) * 2003-11-25 2005-06-01 Univ Leicester Assay for the interaction of L-Ficolin with lipoteichoic acid
ES2730275T3 (es) * 2004-09-22 2019-11-11 Glaxosmithkline Biologicals Sa Composición inmunógena para uso en vacunación contra estafilococos
KR100675379B1 (ko) * 2005-01-25 2007-01-29 삼성전자주식회사 프린팅 시스템 및 프린팅 방법
WO2006107957A2 (fr) 2005-04-04 2006-10-12 Sinexus, Inc. Dispositifs et procedes de traitement des affections sinus paranasaux
US8535707B2 (en) 2006-07-10 2013-09-17 Intersect Ent, Inc. Devices and methods for delivering active agents to the osteomeatal complex
WO2008106763A1 (fr) * 2007-03-08 2008-09-12 The Governors Of The University Of Alberta Endotoxine bactérienne pour la prévention des désordres métaboliques et des infections bactériennes
CN103961193A (zh) 2007-12-18 2014-08-06 因特尔赛克特耳鼻喉公司 自扩展装置及用于其的方法
WO2009122714A1 (fr) 2008-03-31 2009-10-08 大塚製薬株式会社 Procédé de détection de pneumocoque
EP2320832A4 (fr) 2008-08-01 2015-07-29 Intersect Ent Inc Procédés et dispositifs pour sertir des dispositifs auto-dilatables
EP3103502A1 (fr) 2009-05-15 2016-12-14 Intersect ENT, Inc. Dispositifs expansibles et procédés associés
EP2380565A1 (fr) * 2010-03-31 2011-10-26 Lunamed AG Compositions pour traitement dentaire comportant des acides lipotéichoïques ou pièces associées de type mono ou polyglycerphosphates
WO2012116447A1 (fr) * 2011-03-03 2012-09-07 The Governors Of The University Of Alberta Utilisation d'endotoxines bactériennes et d'acides lipotéichoïques pour l'amélioration de la santé post-partum et de la productivité des vaches laitières et de leurs nouveaux nés
EP2574237A1 (fr) * 2011-09-30 2013-04-03 Lunamed AG Utilisation d'un acide lipotéichoïque, mono ou poly-glycérophosphate pour le prétraitement antibactérien et spécialement dans des dispositifs médicaux
CA2856085C (fr) 2011-11-18 2020-06-30 National Research Council Of Canada Acide lipoteichoique de clostridium difficile et utilisations de celui-ci
KR20140082206A (ko) * 2012-12-24 2014-07-02 서울대학교산학협력단 리포테이코산 또는 그 유도체를 포함하는 생물막 형성 방지 또는 저해제 및 이를 이용한 생물막 형성 방지 또는 저해 방법
WO2014151963A2 (fr) 2013-03-14 2014-09-25 Intersect Ent, Inc. Systèmes, dispositifs et méthode de traitement d'une affection sinusale
EP3936166B1 (fr) 2015-01-22 2023-12-20 Intersect ENT, Inc. Dispositif enduit de médicament pour le traitement des affectations du nez, des oreilles ou de la gorge
US12403291B2 (en) 2019-08-30 2025-09-02 Intersect Ent, Inc. Submucosal bioresorbable drug eluting platform

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant
US5624904A (en) * 1993-11-17 1997-04-29 Massachusetts Institute Of Technology Method for treating gram positive septicemia
US6610293B1 (en) * 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria

Also Published As

Publication number Publication date
US20020051793A1 (en) 2002-05-02
WO2002045742A8 (fr) 2003-03-06
US20030157133A1 (en) 2003-08-21
WO2002045742A3 (fr) 2002-12-12
WO2002045742A2 (fr) 2002-06-13

Similar Documents

Publication Publication Date Title
AU2001288961A1 (en) Lipoteichoic acid immunogenic compositions and methods of making and using thereof
AU2002225855A1 (en) Preparation of nanocrystallites
AU2001255196A1 (en) Compositions and methods for enhancing immunogenicity of antigens
AU2001279284A1 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
AU2001241474A1 (en) Biosensor compositions and methods of use
AU2001285041A1 (en) Sulfur containing polyhydroxyalkanoate compositions and method of production
AU2001294920A1 (en) Chrono delivery formulations and method of use thereof
AU2001281140A1 (en) Anti-plasmodium compositions and methods of use
AU3885301A (en) Anti-mycobacterium compositions and methods of preparing and using same
AU2001222986A1 (en) Dehydroascorbic acid formulations and uses thereof
AU2001271031A1 (en) Cosmetic compositions for reducing and method of using the same
AU2002216346A1 (en) Cabergoline pharmaceutical compositions and methods of use thereof
AU2001266638A1 (en) Compositions containing alpha-sulfofatty acid esters and methods of making the same
AU2001280721A1 (en) Compositions of iodonium compounds and methods and uses thereof
AU2001292667A1 (en) Immunogenic composition of hepatitis c and methods of use thereof
AU2001293048A1 (en) Antiviral compositions and methods of use
AU2002341555A1 (en) Levothyroxine pharmaceutical compositions, methods of making and methods of administration
AU2001265280A1 (en) Preparation of 2-hydroxy-5-oxoproline and analogs thereof
AU2001279729A1 (en) Use of cross-linker and compositions made therefrom
AU2002228711A1 (en) Hydroxy-alkanoic acid ester monomer compositions and methods of making same
AU2001255801A1 (en) Neutralization of phosphate esters, compositions based upon and methods using same
AU2001280208A1 (en) Vaccine preparation containing fatty acid as component
AU2001251352A1 (en) Brake cleaner compositions and method of using same
AU4839100A (en) Methods of using and compositions comprising n-desmethylzolpidem
AU2001297556A1 (en) 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof